paroxysmal abnormality.
In 13 cases of infantile spasms whose EEG showed hypsarhythmia, paroxysmal discharges were completely or remarkably suppressed in 4 cases, partially suppressed in 3 cases, but not improved in 6 cases. Suppression bursts pattern was less improved.
In 5 cases of Lennox syndrome, paroxysmal discharges were markedly improved in 3 cases. In a case of petit mal absence, parxoxysmal discharges were completely suppressed. In all 5 cases whose EEGs were completely improved, paroxysmal discharges reappeared 7 to 30 min after the intravenous injection.
In 2 out of the 5 cases, paroxysmal discharges became severer at reappearance than before the injection.
Among 12 cases whose EEG showed an improvement after the intravenous injection, their clinical seizures were improved in 9 cases, but the clinical effect was mostly transient.
In the majority of the cases whose EEGs were not improved, no clinical effect was observed.
There was a highly significaant correlation between immediate EEG changes and clinical effect of clonazepam (p<0.02 by the chisquare test).
clonazepam; EEG; minor seizures
The anticonvulsive properties of a benzodiazepine derivative, clonazepam (5- 
SUBJECTS AND METHODS
Twenty-one children, 11 boys and 10 girls, with minor seizures ranging from 2 months to 9 years of ages, were subjected to the present study in the ward of Tohoku University Hospital.
The types of seizures and numbers of cases were as follows: infantile spasms in 14 cases, Lennox syndrome in 5, petit mal status in 1, and unclassified abortive seizure in 1.
The etiology for seizures could be clarified in 8 cases.
These included 6 patients with microcephalus, two of which were accompanied with chronic subdural effusion confirmed by the computerized tomography and craniotomy, one with tuberous sclerosis, and one with homocystinuria with 5,10-methylene-tetrahydrofolate reductase defect (Narisawa et al. 1977) . Electroencephalograms were recorded during sleep stage, using a 13-channel electroencephalograph (Toshiba EEG 23-A, Tokyo, Japan). CZP was available in ampules of I mg/ml, to which 1 to 4 ml of solvent was added.
Doses between 0.04 and 0.06 mg per kg of body weight were intravenously injected slowly over a period of 1 to 3 min. EEG was continuously observed before, during and for about 30 min after the injection of CZP. Each EEG tracing was examined as to whether there are changes in the seizure discharges, induction of the fast waves, depression or activation of focal elements, and/or activation of other findings such as sleep spindles.
After an intravenous administration test, each patient, except for Cases 6 and 18, was orally given 0.05 to 0.12 mg per kg of body weight per day of CZP. Most of the patients were given CZP alone until this drug was proved unsatisfactory, except for Cases 16, 19, 20 and 21. The frequency and character of the seizures were observed before and after the treatment of CZP. The effectiveness of the medication was judged to be:
(1) complete; (2) adequately improved, with more than 75% reduction in frequency; (3) significantly improved, with more than 50% reduction in frequency; (4) little or not improved; or (5) worse. The judgement was made after at least 4 weeks of medication.
RESULTS
Results of the immediate changes of EEG after the intravenous administration of CZP in relation to clinical seizure pattern and dominant EEG pattern are presented in Table 1 and summarized in Table 2 . Examples of the changes are shown in Figs. 1 and 2 .
Eight cases showed a complete or remarkable suppression of seizure activities in EEG, but all the cases showed a reappearance of seizure activities within 6 to 30 min after the injection. In 2 out of the 8 cases , seizure activities at reappearance were severer than before the injection of CZP . Four cases showed a partial suppression of seizure activities. Two of the 4 cases showed a reappearance of seizure activities within 5 to 20 min after the injection . Nine cases showed unchanged seizure activities by the intravenous injection of CZP .
Effect of oral treatment of CZP on the clinical seizures are as follows . Six cases Fig. 1 . Electroencephalograms of Case 7. Spike discharges were scarcely observed in C3-P3 and C4-P4 leads I min after the injection of CZP. Paroxysmal poly-spike-wave complexes reappeared 9 min after the injection.
showed a good result with a complete cessation of clinical seizures, but a reappearance of seziures was seen in 5 of the cases.
Three cases were adequately controlled and 2
were under a significant control. Seven cases showed poor or no effect. In one case, the seizures got worse than before CZP therapy. Correlation between EEG changes after the intravenous injection and the effect of oral treatment of CZP on clinical seizures is shown in Table 3 . Among 12 cases whose EEG showed an improvement after intravenous injection of CZP , an improvement of clinical seizures was observed in 9 cases , although the seizures recurred in 7 of the 9 cases. In 9 cases whose EEG showed no change after Bianchi Saus et al. (1973) reported that intravenous injection of CZP showed a stronger effect on generalized EEG abnormalities than on focal abnormalities and no effect on hypsarhythmia. Hakkinen (1973) found that in a case of 25 years old patient with Lennox syndrome, the discharges disappeared after the injection of 2 mg of CZP, and there was a tonic fits, with generalized high amplitude and high frequency discharges lasting 4 seconds about 5 min after the completion of the slow injection. Rosenmayr and Groh (1973) reported that in 37 cases with generalized spike-wave discharges, 18 were normalized, 10 were remarkably im proved, and 9 were unchanged. According to these previous literatures, EEG changes after intravenous injection of CZP were most remarkable in generalized spike-wave pattern. The present study also showed that generalized spike-wave discharges were most remarkably improved, but hypsarhythmia was not so remarkably improved. In the EEG features of Lennox syndrome, diffuse slow spike-wave pattern was more improved than poly-spike-wave pattern. As for hypsarhythmia, typical hypsarhythmia was more improved than periodic hypsarhythmia by intravenous injection of CZP (Table 2) . Thus, EEG of diffuse or generalized seizure discharges may be most sensitive to intravenous administra tion of CZP. EEG of focal or periodic pattern was rather insensitive to intravenous administration of CZP. Martin and Hirt (1973) reported that regression of the hypsarhythmia was observed after intravenous injection of CZP. In our 2 cases, the appearance of epileptic discharges became more frequent 7 to 13 min after injection of CZP. Effect of intravenous injection of CZP on EEG was temporary and it may be supposed that CZP rather activates epileptic activities after transient suppression.
Binachi Saus et al. (1973) mentioned that the intravenous injection of CZP was useful as a prognostic test of the future results of oral treatment. Groh and Rosenmayr (1974) reported that there was a highly significant correlation between these two variables: the greater the EEG normalization on intravenous administra tion of CZP, the better, as a general rule, were the prospects for successful longterm treatment with this drug. In the present study, a high correlation between EEG changes and the effect on clinical seizure control was also found (Table 3) . These results indicate that CZP i.v. test is useful to predict the effectiveness of oral therapy.
It was reported that CZP administered intravenously or orally produces an in crease in low-voltage fast activity in a high percentage of patients (Martin and Hirt 1973; Rosenmayr and Groh 1973; Fazio et al. 1975 ). In our study, an increase in fast activity after the injection was observed only in 4 of 21 cases . Laguna and Korein (1972) reported that the appearance of low voltage fast activity was a com moner effect of intravenous injection of diazepam, one of derivatives of benzodiaze pine, and that it was less prominent on the side with focal brain damage. Lombroso (1966) claimed that diazepam-induced low voltage fast activity was similar to that following injection of short acting barbiturate and might have lateralizing value (Lombroso and Erba 1970) . In the present study , CZP-induced fast activity did not point out the focus of brain damage, even in a case having localized epileptic activity. CZP i.v. test may not have lateralizing value in minor seizures.
